Insurance specialty broker Ryan Specialty (NYSE:RYAN) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 13.2% year on year to $751.2 million. Its non-GAAP profit of $0.45 per share was 8.3% below analysts’ consensus estimates.
Insurance specialty broker Ryan Specialty (NYSE:RYAN) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 13.2% year on year to $751.2 million. Its non-GAAP profit of $0.45 per share was 8.3% below analysts’ consensus estimates.
Shares of insurance specialty broker Ryan Specialty (NYSE:RYAN) fell 8.3% in the afternoon session after investor concerns grew over a controversial bill moving through the Florida Legislature that could significantly alter the state's insurance market.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Shareholders of Ryan Specialty would probably like to forget the past six months even happened. The stock dropped 20.7% and now trades at $47.55. This may have investors wondering how to approach the situation.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Growth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. But cutbacks in corporate spending and the threat of new AI products have kept sentiment in check,
and over the past six months, the industry’s 2.3% return has trailed the S&P 500 by 7.6 percentage points.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the insurance brokers industry, including Ryan Specialty (NYSE:RYAN) and its peers.
Insurance specialty broker Ryan Specialty (NYSE:RYAN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 24.8% year on year to $754.6 million. Its non-GAAP profit of $0.47 per share was in line with analysts’ consensus estimates.
